SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

10x Genomics Reports Third-Quarter 2026 Financial Results

10x Genomics reported results for the quarter ended September 30, 2026.

TXG

PLEASANTON, Calif., Nov. 5, 2026 // -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today reported financial results for the third quarter ended September 30, 2026.Recent Updates"The biggest highlight of t…

Related stories